Selectable Temperature:170 Hour, Cold Shipping Container

描述(由申请者提供)：该项目旨在将大型 可容纳选定温度的冷藏箱容量(15至27升) 在1摄氏度内暴露在环境中170小时内-20至+20摄氏度 温度高达43摄氏度，它将达到或超过 世界卫生组织(WHO)远程大型冷藏箱(E4/CB.2) 扩大免疫接种方案。参与运输的卫生工作者和 疫苗、血液产品和生物样本的处理需要这样做 必须严格控制的样品或产品的能力 延长期限的条件。UTD Inc.将应用几项创新 接近现有公司持有恒温专利的方法 利用两个相变之间的热平衡的装运集装箱 恒温源实现恒温可选中间体 温度。客观设计将使用最先进的绝缘材料 增加相对货运量的技术。受控变量 导体将提供轻松的温度选择性。第一阶段工作将包括 台架样机的设计和制造，台架的设计和验证 控制系统，并对试验台样机进行了可行性论证，满足 客观的设计特点。重点研究领域包括设计 一种适合大规模生产的绝缘系统，以及一种 控制系统反应灵敏、稳定。 建议的商业应用：不可用

DESCRIPTION (provided by applicant): This project aims to commercialize a large capacity (15 to 27 liters) cold box capable of holding a selected temperature between -20 to +20C within 1 C for 170 hours while exposed to ambient temperatures up to 43 C. It will meet or exceed the performance standards of a large cold box, long range (E4/CB.2) of the World Health Organization (WHO) Expanded Program on Immunization. Health workers involved in the shipment and handling of vaccines, blood products, and biological samples need this capability for samples or products that must be held at carefully controlled conditions for extended periods. UTD Inc. will apply several innovative approaches to an existing company held patent on a constant temperature shipment container, which uses the thermal equilibrium between two phase-change constant temperature sources to achieve a constant selectable intermediate temperature. The objective design will use state-of-the-art insulation technology to increase the relative cargo volume. Controlled variable conductors will provide easy temperature selectivity. Phase I work will include the design and fabrication of a bench prototype, design and validation of the control system, and a feasibility demonstration of the bench prototype to meet the objective design characteristics. Key research areas include the design of an insulation system suitable for mass production, and the development of a responsive and stable control system. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE